Lycia Therapeutics, Inc. (LYCA) stock
LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)
Close on Nov 18, 2026Market cap –P/E –Yield –
Statistics
No statistics for Lycia Therapeutics yet
Statistics are calculated from the financial statements Lycia Therapeutics files with the SEC and the daily share price.
See a number that looks wrong?